280 related articles for article (PubMed ID: 25032507)
1. Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.
Ma A; Yu W; Li F; Bleich RM; Herold JM; Butler KV; Norris JL; Korboukh V; Tripathy A; Janzen WP; Arrowsmith CH; Frye SV; Vedadi M; Brown PJ; Jin J
J Med Chem; 2014 Aug; 57(15):6822-33. PubMed ID: 25032507
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of SETD8 inhibitors.
Ma A; Yu W; Xiong Y; Butler KV; Brown PJ; Jin J
Medchemcomm; 2014 Dec; 5(12):1892-1898. PubMed ID: 25554733
[TBL] [Abstract][Full Text] [Related]
3. Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors.
Milite C; Feoli A; Viviano M; Rescigno D; Mai A; Castellano S; Sbardella G
ChemMedChem; 2016 Aug; 11(16):1680-5. PubMed ID: 27411844
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer.
Wada M; Kukita A; Sone K; Hamamoto R; Kaneko S; Komatsu M; Takahashi Y; Inoue F; Kojima M; Honjoh H; Taguchi A; Kashiyama T; Miyamoto Y; Tanikawa M; Tsuruga T; Mori-Uchino M; Wada-Hiraike O; Osuga Y; Fujii T
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33339442
[TBL] [Abstract][Full Text] [Related]
5. The emerging role of lysine methyltransferase SETD8 in human diseases.
Milite C; Feoli A; Viviano M; Rescigno D; Cianciulli A; Balzano AL; Mai A; Castellano S; Sbardella G
Clin Epigenetics; 2016; 8():102. PubMed ID: 27688818
[TBL] [Abstract][Full Text] [Related]
6. Nahuoic acid A produced by a Streptomyces sp. isolated from a marine sediment is a selective SAM-competitive inhibitor of the histone methyltransferase SETD8.
Williams DE; Dalisay DS; Li F; Amphlett J; Maneerat W; Chavez MA; Wang YA; Matainaho T; Yu W; Brown PJ; Arrowsmith CH; Vedadi M; Andersen RJ
Org Lett; 2013 Jan; 15(2):414-7. PubMed ID: 23272941
[TBL] [Abstract][Full Text] [Related]
7. The Use of Nucleosome Substrates Improves Binding of SAM Analogs to SETD8.
Strelow JM; Xiao M; Cavitt RN; Fite NC; Margolis BJ; Park KJ
J Biomol Screen; 2016 Sep; 21(8):786-94. PubMed ID: 27369108
[TBL] [Abstract][Full Text] [Related]
8. Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression.
Takawa M; Cho HS; Hayami S; Toyokawa G; Kogure M; Yamane Y; Iwai Y; Maejima K; Ueda K; Masuda A; Dohmae N; Field HI; Tsunoda T; Kobayashi T; Akasu T; Sugiyama M; Ohnuma S; Atomi Y; Ponder BA; Nakamura Y; Hamamoto R
Cancer Res; 2012 Jul; 72(13):3217-27. PubMed ID: 22556262
[TBL] [Abstract][Full Text] [Related]
9. Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase.
Butler KV; Ma A; Yu W; Li F; Tempel W; Babault N; Pittella-Silva F; Shao J; Wang J; Luo M; Vedadi M; Brown PJ; Arrowsmith CH; Jin J
J Med Chem; 2016 Nov; 59(21):9881-9889. PubMed ID: 27804297
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule inhibitors of SETD8 with cellular activity.
Blum G; Ibáñez G; Rao X; Shum D; Radu C; Djaballah H; Rice JC; Luo M
ACS Chem Biol; 2014 Nov; 9(11):2471-8. PubMed ID: 25137013
[TBL] [Abstract][Full Text] [Related]
11. Structures of Nahuoic Acids B-E Produced in Culture by a Streptomyces sp. Isolated from a Marine Sediment and Evidence for the Inhibition of the Histone Methyl Transferase SETD8 in Human Cancer Cells by Nahuoic Acid A.
Williams DE; Izard F; Arnould S; Dalisay DS; Tantapakul C; Maneerat W; Matainaho T; Julien E; Andersen RJ
J Org Chem; 2016 Feb; 81(4):1324-32. PubMed ID: 26815947
[TBL] [Abstract][Full Text] [Related]
12. Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines.
Liu F; Chen X; Allali-Hassani A; Quinn AM; Wigle TJ; Wasney GA; Dong A; Senisterra G; Chau I; Siarheyeva A; Norris JL; Kireev DB; Jadhav A; Herold JM; Janzen WP; Arrowsmith CH; Frye SV; Brown PJ; Simeonov A; Vedadi M; Jin J
J Med Chem; 2010 Aug; 53(15):5844-57. PubMed ID: 20614940
[TBL] [Abstract][Full Text] [Related]
13. The Histone Methyltransferase SETD8 Regulates the Expression of Tumor Suppressor Genes via H4K20 Methylation and the p53 Signaling Pathway in Endometrial Cancer Cells.
Kukita A; Sone K; Kaneko S; Kawakami E; Oki S; Kojima M; Wada M; Toyohara Y; Takahashi Y; Inoue F; Tanimoto S; Taguchi A; Fukuda T; Miyamoto Y; Tanikawa M; Mori-Uchino M; Tsuruga T; Iriyama T; Matsumoto Y; Nagasaka K; Wada-Hiraike O; Oda K; Hamamoto R; Osuga Y
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358786
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a.
Liu F; Chen X; Allali-Hassani A; Quinn AM; Wasney GA; Dong A; Barsyte D; Kozieradzki I; Senisterra G; Chau I; Siarheyeva A; Kireev DB; Jadhav A; Herold JM; Frye SV; Arrowsmith CH; Brown PJ; Simeonov A; Vedadi M; Jin J
J Med Chem; 2009 Dec; 52(24):7950-3. PubMed ID: 19891491
[TBL] [Abstract][Full Text] [Related]
15. USP29 Deubiquitinates SETD8 and Regulates DNA Damage-Induced H4K20 Monomethylation and 53BP1 Focus Formation.
Hernández-Reyes Y; Paz-Cabrera MC; Freire R; Smits VAJ
Cells; 2022 Aug; 11(16):. PubMed ID: 36010569
[TBL] [Abstract][Full Text] [Related]
16. Roles for the methyltransferase SETD8 in DNA damage repair.
Xu L; Zhang L; Sun J; Hu X; Kalvakolanu DV; Ren H; Guo B
Clin Epigenetics; 2022 Mar; 14(1):34. PubMed ID: 35246238
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of histone methyltransferase SETD8 represses DNA virus replication.
Chen L; Yang C; Tang SB; Long QY; Chen JD; Wu M; Li LY
Cell Insight; 2022 Jun; 1(3):100033. PubMed ID: 37193046
[TBL] [Abstract][Full Text] [Related]
18. The SETD8/PR-Set7 Methyltransferase Functions as a Barrier to Prevent Senescence-Associated Metabolic Remodeling.
Tanaka H; Takebayashi SI; Sakamoto A; Igata T; Nakatsu Y; Saitoh N; Hino S; Nakao M
Cell Rep; 2017 Feb; 18(9):2148-2161. PubMed ID: 28249161
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship studies of G9a-like protein (GLP) inhibitors.
Xiong Y; Li F; Babault N; Wu H; Dong A; Zeng H; Chen X; Arrowsmith CH; Brown PJ; Liu J; Vedadi M; Jin J
Bioorg Med Chem; 2017 Aug; 25(16):4414-4423. PubMed ID: 28662962
[TBL] [Abstract][Full Text] [Related]
20. LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2.
Nguyen H; Allali-Hassani A; Antonysamy S; Chang S; Chen LH; Curtis C; Emtage S; Fan L; Gheyi T; Li F; Liu S; Martin JR; Mendel D; Olsen JB; Pelletier L; Shatseva T; Wu S; Zhang FF; Arrowsmith CH; Brown PJ; Campbell RM; Garcia BA; Barsyte-Lovejoy D; Mader M; Vedadi M
J Biol Chem; 2015 May; 290(22):13641-53. PubMed ID: 25825497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
